Mila B.
- Country
- Bulgaria
- Department
- Clinic of Chidren Gastroenterology
Research Overview
- A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age with Functional Constipation (FC).
- Evaluation of Upadacitinib Efficacy, Safety, and Pharmacokinetics in Pediatric Patients with Moderate to Severe Crohn's Disease: A Phase 3 Multicenter Study
Data & Insights
Has run more than one trial at 30 of 79 partner sites.
Specializations
Inflammatory Bowel Disease Research
The investigator specializes in treating pediatric patients with inflammatory bowel diseases, with particular focus on Crohn's disease and ulcerative colitis. Their research encompasses innovative therapeutic approaches for moderately to severely active forms of these conditions.
- Advanced Biological Therapies
- Novel Treatment Assessment
- Pediatric IBD Management
Their work includes evaluating treatments like upadacitinib, vedolizumab, and risankizumab in pediatric populations.
Pediatric Gastroenterology
The investigator focuses on treating gastrointestinal disorders in children across different age groups, from infants as young as 6 months to adolescents. Their expertise includes managing functional constipation and other digestive system disorders in pediatric patients.
- Age-Specific Treatment Approaches
- Long-term Safety Monitoring
- Therapeutic Response Assessment
Special attention is given to developing age-appropriate treatment strategies for young patients with gastrointestinal conditions.
Clinical Pharmacology
The investigator conducts research on pharmacokinetics and therapeutic efficacy of various treatments in pediatric populations. Their work includes studying medication responses in children who have shown inadequate response to conventional therapies.
- Drug Safety Evaluation
- Dose-Finding Studies
- Treatment Response Analysis
Focus areas include evaluating drug effectiveness and safety profiles in pediatric patients with chronic gastrointestinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.